Interpace Biosciences (IDXG) Reports Q1 EPS of $0.03

Interpace Biosciences (OTC: IDXG) reported Q1 EPS of $0.03. Revenue for the quarter came in at $9.03 million.

For earnings history and earnings-related data on Interpace Biosciences (IDXG) click here.

You May Also Be Interested In

• Kronos Worldwide (KRO) Tops Q2 EPS by 17c
• FTAI Infrastructure Inc. (FIP) Misses Q2 EPS by 99c
• South Bow Corporation (SOBO) Reports Q2 EPS of $0.50